By 2015, it is anticipated that the molecular imaging (MI) market will achieve a value of over $6 billion, according to a new report on companiesandmarkets.com. Although the growth and development of the market was tempered by the recession, there are indications that new products and technologies will have a positive impact on the industry in the near future.
Molecular Imaging: A Market Coming of Age
The molecular imaging industry is still in the early stages of development, driven by innovation and R&D. The sector represents distinct opportunities for growth, as molecular imaging technology can improve and enhance diagnostics and research activities. Key applications are likely to be found in neurological diseases - especially Alzheimer's disease, oncology, cardiovascular disease, and drug development.
Consolidation is expected to be a key trend in the MI industry going forward, as the current market landscape is highly fragmented with many participants. The complex technologies used by MI mean that market entry is restricted to those with strong financing; licensing and M&A deals are therefore expected to increase in popularity as medical diagnostics and pharmaceutical companies compete to establish dominance.
For the purposes of this report, the industry is segmented into the following: Nuclear Imaging;
Pre-Clinical Imaging Systems; Molecular Imaging End-Use Products Market, and Radiopharmaceuticals. The market value for each segment (in US$) is forecast to 2015.